Insiders Oncolytics Biotech Inc. Nasdaq

Equities

ONCY

CA6823108759

Market Closed - Nasdaq Other stock markets 21:00:00 10/06/2024 BST			5-day change	1st Jan Change
1.02 ^USD	-2.86%		-4.67%	-24.44%

05-24	Oncolytics Biotech Inc. Presents Two Abstracts At the 2024 American Society of Clinical Oncology Annual Meeting	CI
05-24	Oncolytics Biotech Says ASCO Abstracts Highlight Pelareorep's Treatment Potential in Pancreatic Cancer	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Oncolytics Biotech Inc. Appoints Patricia S. Andrews to Its Board of Directors	01-09	CI
Imugene Names Chief Medical Officer; Shares Rise 3%	04/10/22	MT
Oncolytics Biotech(R) Inc. Appoints Jonathan Rigby to its Board of Directors	07/09/22	CI
Oncolytics Biotech Appoints James T. Parsons to its Board of Directors; Formerly CFO of Trillium Therapeutics	17/06/22	MT
Oncolytics Biotech Inc. Appoints James T. Parsons to its Board of Directors	17/06/22	CI
Oncolytics Biotech Q4 Loss Narrows on Lower Expenses	03/03/22	MT
Oncolytics Biotech Inc. Promotes Thomas C. Heineman to Chief Medical Officer	03/03/22	CI
Oncolytics Promotes Thomas C. Heineman, M.D., Ph.D., to Chief Medical Officer	21/12/21	MT
Oncolytics Biotech Inc. Promotes Thomas C. Heineman, M.D., Ph.D., to Chief Medical Officer	21/12/21	CI
Oncolytics Biotech Inc. Appoints Richard Vile, Ph.D., to Its Scientific Advisory Board	19/10/20	CI
Oncolytics Biotech Inc. Appoints Thomas C. Heineman as Global Head of Clinical Development and Operations	04/08/20	CI
Oncolytics Biotech Inc. Appoints Leonard Kruimer to Board of Directors	17/10/19	CI
Oncolytics Biotech Inc. Announces Appointment of Rita Laeufle as Chief Medical Officer	29/11/18	CI
Andres Gutierrez to Resign as a Chief Medical Officer of Oncolytics Biotech Inc., Effective April 23, 2018	17/04/18	CI
Oncolytics Biotech Inc. Announces Scientific Advisory Board Appointments	30/11/17	CI
Oncolytics Biotech Inc. Appoints Deborah M. Brown to the Board of Directors	02/11/17	CI
Oncolytics Biotech Inc. Appoints Matt Coffey as President and Chief Executive Officer	19/01/17	CI
Oncolytics Biotech Inc. Announces Resignation of Brad Thompson from Board of Directors	07/12/16	CI
Oncolytics Biotech® Inc. Announces Executive Changes	10/11/16	CI
Oncolytics Biotech Inc. Announces Management Changes	02/11/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Oncolytics Biotech Inc. Nasdaq

Equities

ONCY

CA6823108759

Insiders

Filters